As of January 22, 2025, Precigen (PGEN) has a market cap of $0.33 billion USD. According to our data, Precigen is ranked No.6573 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.33 B |
0.89%
|
Dec 31, 2024 | $0.33 B |
-16.42%
|
Dec 29, 2023 | $0.39 B |
-11.84%
|
Dec 30, 2022 | $0.45 B |
-59.03%
|
Dec 31, 2021 | $1.09 B |
-63.63%
|
Dec 31, 2020 | $2.99 B |
86.13%
|
Dec 31, 2019 | $1.60 B |
-16.21%
|
Dec 31, 2018 | $1.92 B |
-43.23%
|
Dec 29, 2017 | $3.37 B |
-52.59%
|
Dec 30, 2016 | $7.12 B |
-19.40%
|
Dec 31, 2015 | $8.83 B |
9.52%
|
Dec 31, 2014 | $8.06 B |
15.67%
|
Dec 31, 2013 | $6.97 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
Verve Therapeutics
VERV
|
$0.66 B |
0.000 M
|
USA
|
Market Cap | = | PGEN Stock Price | * | PGEN Shares Outstanding |
= | $1.13 | * | 0.29 B | |
= | $0.33 B |